Natural Products from Plants and Algae for Treatment of Alzheimer’s Disease: A Review

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · see citing works

Alzheimer's disease: the amyloid cascade hypothesis

Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · see citing works

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814 · see citing works

Phases of Aβ-deposition in the human brain and its relevance for the development of AD

Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490 · see citing works

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies

Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204 · see citing works

Acetylcholinesterase Inhibitors: Pharmacology and Toxicology

Colovic, M. B., Krstic, D. Z., Lazarevic-Pasti, T. D., Bondzic, A. M., & Vasic, V. M. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311030006 · Cited by 2,611 · see citing works

Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression

Wang, X., Sun, G., Feng, T., Zhang, J., Huang, X., Wang, T., Xie, Z., Chu, X., Yang, J., Wang, H., et al. (2019) · Cell Research · doi:10.1038/s41422-019-0216-x · Cited by 1,144 · see citing works

A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia

Le Bars, P. L. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550160047037 · Cited by 966 · see citing works

Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau

Caccamo, A., Majumder, S., Richardson, A., Strong, R., & Oddo, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.100420 · Cited by 881 · see citing works

Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based Therapeutics

Selkoe, D. J., & Schenk, D. (2003) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140248 · Cited by 816 · see citing works

Tau and neurodegenerative disease: the story so far

Iqbal, K., Liu, F., & Gong, C.-X. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.225 · Cited by 806 · see citing works

Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus

Puzzo, D., Privitera, L., Leznik, E., Fà, M., Staniszewski, A., Palmeri, A., & Arancio, O. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2692-08.2008 · Cited by 740 · see citing works

Ginkgo biloba for Prevention of Dementia A Randomized Controlled Trial

DeKosky, S. T. (2008) · JAMA · doi:10.1001/jama.2008.683 · Cited by 671 · see citing works

Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration

Walter, L. M., Franklin, A. A., Witting, A., Wade, C. B., Xie, Y., Kunos, G., Mackie, K., & Stella, N. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01398.2003 · Cited by 666 · see citing works

Clinical trials and late‐stage drug development for <scp>A</scp>lzheimer's disease: an appraisal from 1984 to 2014

Schneider, L. S., Mangialasche, F., Andreasen, N., Feldman, H., Giacobini, E., Jones, R., Mantua, V., Mecocci, P., Pani, L., Winblad, B., et al. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12191 · Cited by 651 · see citing works

The Efficacy of Ginkgo biloba on Cognitive Function in Alzheimer Disease

Oken, B., Storzbach, D. M., & Kaye, J. A. (1998) · Archives of Neurology · doi:10.1001/archneur.55.11.1409 · Cited by 585 · see citing works

CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure

Ranković, Z. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501535r · Cited by 582 · see citing works

Panax ginseng pharmacology: A nitric oxide link?

Gillis, C. N. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00193-7 · Cited by 568 · see citing works

Cholinesterase inhibitors: new roles and therapeutic alternatives

Giacobini, E. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2003.11.017 · Cited by 559 · see citing works

Alzheimer’s disease drug development pipeline: 2021

Cummings, J., Lee, G., Zhong, K., Fonseca, J., & Taghva, K. (2021) · Alzheimer's &amp; Dementia: Translational Research &amp; Clinical Interventions · doi:10.1002/trc2.12179 · Cited by 539 · see citing works

Sulfated Polysaccharides Extracted from Sea Algae as Potential Antiviral Drugs

Witvrouw, M., & Clercq, E. D. (1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(96)00563-0 · Cited by 531 · see citing works

Alzheimer disease therapy—moving from amyloid-β to tau

Giacobini, E., & Gold, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.223 · Cited by 483 · see citing works

Natural Dietary Supplementation of Anthocyanins via PI3K/Akt/Nrf2/HO-1 Pathways Mitigate Oxidative Stress, Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer’s Disease

Ali, T., Kim, T. H., Rehman, S. U., Khan, M. S., Amin, F. U., Khan, M., Ikram, M. A., & Kim, M. O. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0798-6 · Cited by 477 · see citing works

Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement

Esposito, G., Scuderi, C., Valenza, M., Togna, G. I., Latina, V., De Filippis, D., Cipriano, M., Carratù, M. R., Iuvone, T., & Steardo, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028668 · Cited by 410 · see citing works

Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer’s Disease

Martín-Moreno, A. M., Reigada, D., Ramírez, B. G., Mechoulam, R., Innamorato, N. G., Cuadrado, A., & CEBALLOS, M. L. D. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.071290 · Cited by 402 · see citing works

Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders

Singh, S. K., Srivastav, S., Castellani, R. J., Plascencia‐Villa, G., & Perry, G. L. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00767-8 · Cited by 402 · see citing works

Inducing Autophagy by Rapamycin Before, but Not After, the Formation of Plaques and Tangles Ameliorates Cognitive Deficits

Majumder, S., Richardson, A. G., Strong, R., & Oddo, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025416 · Cited by 401 · see citing works

Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial

Vellas, B. J., Coley, N., Ousset, P., Berrut, G., Dartigues, J., Dubois, B., Grandjean, H., Pasquier, F., Piette, F., Robert, P. H., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70206-5 · Cited by 401 · see citing works

Proof of Efficacy of the Ginkgo Biloba Special Extract EGb 761 in Outpatients Suffering from Mild to Moderate Primary Degenerative Dementia of the Alzheimer Type or Multi-infarct Dementia

Kanowski, S., Herrmann, W., Stephan, K., Wierich, W., & Hörr, R. (1996) · Pharmacopsychiatry · doi:10.1055/s-2007-979544 · Cited by 369 · see citing works

Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis

Sipe, J. D., Benson, M. D., Buxbaum, J. N., Ikeda, S.-I., Merlini, G., Saraiva, M. J., & Westermark, P. (2010) · Amyloid · doi:10.3109/13506129.2010.526812 · Cited by 363 · see citing works

Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology

Schilling, S., Zeitschel, U., Hoffmann, T., Heiser, U., Francke, M., Kehlen, A., Holzer, M., Hutter-Paier, B., Prokesch, M., Windisch, M., et al. (2008) · Nature Medicine · doi:10.1038/nm.1872 · Cited by 357 · see citing works

Galantamine Is an Allosterically Potentiating Ligand of Neuronal Nicotinic but Not of Muscarinic Acetylcholine Receptors

Samochocki, M., Höffle‐Maas, A., Fehrenbacher, A., Jostock, R., Ludwig, J., Christner, C., Radina, M., Zerlin, M., Ullmer, C., Pereira, E. F. R., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.045773 · Cited by 345 · see citing works

Anti-inflammatory effects of fucoidan through inhibition of NF-κB, MAPK and Akt activation in lipopolysaccharide-induced BV2 microglia cells

Park, H. Y., Han, M. H., Park, C., Jin, C., Kim, G., Choi, I., Kim, N. D., Nam, T., Kwon, T. K., & Choi, Y. H. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.04.020 · Cited by 321 · see citing works

Endogenous amyloid‐β is necessary for hippocampal synaptic plasticity and memory

Puzzo, D., Privitera, L., Fà, M., Staniszewski, A., Hashimoto, G., Aziz, F., Sakurai, M., Ribé, E. M., Troy, C. M., Mercken, M. H., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22313 · Cited by 320 · see citing works

Galantamine — a Novel Cholinergic Drug with a Unique Dual Mode of Action for the Treatment of Patients with Alzheimer's Disease

Lilienfeld, S. (2002) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2002.tb00221.x · Cited by 309 · see citing works

Cannabidiol <i>in vivo</i> blunts β‐amyloid induced neuroinflammation by suppressing IL‐1β and iNOS expression

Esposito, G., Scuderi, C., Savani, C., Steardo, L., De Filippis, D., Cottone, P., Iuvone, T., Cuomo, V, & Steardo, L. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707337 · Cited by 308 · see citing works

Anthocyanins Reversed D-Galactose-Induced Oxidative Stress and Neuroinflammation Mediated Cognitive Impairment in Adult Rats

Rehman, S. U., Shah, S. A., Ali, T., Chung, J. I., & Kim, M. O. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9604-5 · Cited by 285 · see citing works

Current Research Therapeutic Strategies for Alzheimer’s Disease Treatment

Folch, J., Petrov, D., Ettcheto, M., Abad, S., Sánchez-López, E., García, M. L., Olloquequi, J., Beas-Zarate, C., Auladell, C., & Camins, A. (2016) · Neural Plasticity · doi:10.1155/2016/8501693 · Cited by 270 · see citing works

The Cholinergic System Modulates Memory and Hippocampal Plasticity via Its Interactions with Non-Neuronal Cells

Maurer, S. V., & Williams, C. L. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01489 · Cited by 266 · see citing works

The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF)

Smith, P. F., Maclennan, K., & Darlington, C. L. (1996) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(96)01379-7 · Cited by 262 · see citing works

The marijuana component cannabidiol inhibits β-amyloid-induced tau protein hyperphosphorylation through Wnt/β-catenin pathway rescue in PC12 cells

Esposito, G., Filippis, D. D., Carnuccio, R., Izzo, A. A., & Iuvone, T. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0025-1 · Cited by 252 · see citing works

Anti-inflammatory activity of edible brown alga Eisenia bicyclis and its constituents fucosterol and phlorotannins in LPS-stimulated RAW264.7 macrophages

Jung, H. A., Jin, S. E., Ahn, B. R., Lee, C. M., & Choi, J. S. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.05.061 · Cited by 243 · see citing works

Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease

Zetterberg, H. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.90 · Cited by 234 · see citing works

Effect of omega-3 fatty acids supplementation on endothelial function: A meta-analysis of randomized controlled trials

Wang, Q., Liang, X., Wang, L., Lu, X., Huang, J., Cao, J., Li, H., & Gu, D. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.01.006 · Cited by 233 · see citing works

Inhibition of Glycogen Synthase Kinase-3 Ameliorates β-Amyloid Pathology and Restores Lysosomal Acidification and Mammalian Target of Rapamycin Activity in the Alzheimer Disease Mouse Model

Avrahami, L., Farfara, D., Shaham-Kol, M., Vassar, R. J., Frenkel, D., & Eldar-Finkelman, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.409250 · Cited by 232 · see citing works

Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in β-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-κB involvement

Esposito, G., De Filippis, D., Maiuri, M. C., De Stefano, D., Carnuccio, R., & Iuvone, T. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.01.047 · Cited by 225 · see citing works

A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia

Xiao, S., Chan, P., Wang, T., Hong, Z., Wang, S., Kuang, W., He, J., Pan, X., Zhou, Y., Ji, Y., et al. (2021) · Alzheimer's Research &amp; Therapy · doi:10.1186/s13195-021-00795-7 · Cited by 224 · see citing works

Neuroprotective Effects of Ginseng Total Saponin and Ginsenosides Rb1 and Rg1 on Spinal Cord Neurons in Vitro

Liao, B., Newmark, H. L., & Zhou, R. (2002) · Experimental Neurology · doi:10.1006/exnr.2001.7841 · Cited by 213 · see citing works

Cytoprotective effect of fucoxanthin isolated from brown algae Sargassum siliquastrum against H2O2-induced cell damage

Heo, S., Ko, S., Kang, S., Kang, H., Kim, J.-P., Kim, S.-H., Lee, K.-W., Cho, M.-G., & Jeon, Y. (2008) · European Food Research and Technology · doi:10.1007/s00217-008-0918-7 · Cited by 210 · see citing works

Chronic Rapamycin Restores Brain Vascular Integrity and Function Through NO Synthase Activation and Improves Memory in Symptomatic Mice Modeling Alzheimer’s Disease

Lin, A., Zheng, W., Halloran, J. J., Burbank, R. R., Hussong, S. A., Hart, M. J., Javors, M. A., Shih, Y. I., Muir, E. R., Fonseca, R. S., et al. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.82 · Cited by 208 · see citing works

Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death

Mukhopadhyay, P., Rajesh, M., Horváth, B., Bátkai, S., Park, O., Tanchian, G., Gao, R. Y., Patel, V., Wink, D. A., Liaudet, L., et al. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.02.021 · Cited by 206 · see citing works

Benefits of curcumin in brain disorders

Bhat, A., Mahalakshmi, A. M., Ray, B., Tuladhar, S., Hediyal, T. A., Manthiannem, E., Jagadeeswari, P., Chandra, R., Chidambaram, S. B., & Sakharkar, M. K. (2019) · BioFactors · doi:10.1002/biof.1533 · Cited by 202 · see citing works

Comparison of Cannabidiol, Antioxidants, and Diuretics in Reversing Binge Ethanol-Induced Neurotoxicity

Hamelink, C., Hampson, A. J., Wink, D. A., Eiden, L. E., & Eskay, R. L. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085779 · Cited by 190 · see citing works

Sodium Oligomannate: First Approval

Syed, Y. Y. (2020) · Drugs · doi:10.1007/s40265-020-01268-1 · Cited by 187 · see citing works

Heterogeneity in Alzheimer’s Disease Diagnosis and Progression Rates: Implications for Therapeutic Trials

Duara, R., & Barker, W. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01185-z · Cited by 187 · see citing works

Ginkgo biloba Extract in Alzheimer’s Disease: From Action Mechanisms to Medical Practice

Shi, C., Liu, J., Wu, F., & Yew, D. T. W. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11010107 · Cited by 186 · see citing works

Neuroprotective Effects of Huperzine A

Wang, R., & Tang, X. C. (2005) · Neurosignals · doi:10.1159/000085387 · Cited by 175 · see citing works

Ginsenosides: Are Any of them Candidates for Drugs Acting on the Central Nervous System?

Nah, S.-Y., Kim, D., & Rhim, H. (2007) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2007.00023.x · Cited by 175 · see citing works

Acetyl- and butyrylcholinesterase inhibitory activities of sterols and phlorotannins from Ecklonia stolonifera

Yoon, N. Y., Chung, H. Y., Kim, H. R., & Choi, J. S. (2008) · Fisheries Science · doi:10.1111/j.1444-2906.2007.01511.x · Cited by 173 · see citing works

Antioxidant activities of sulfated polysaccharide fractions from Porphyra haitanesis

Zhang, Q., Yu, P., Li, Z., Zhang, H., Xu, Z., & Li, P. (2003) · Journal of Applied Phycology · doi:10.1023/a:1025137728525 · Cited by 173 · see citing works

Antioxidant and anti-inflammatory activities of porphyran isolated from discolored nori (Porphyra yezoensis)

Isaka, S., Cho, K., Nakazono, S., Abu, R., Ueno, M., Kim, D., & Oda, T. (2014) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.11.043 · Cited by 168 · see citing works

Anti-oxidant activities of fucosterol from the marine algaePelvetia siliquosa

Lee, S., Lee, Y. S., Jung, S. H., Kang, S. S., & Shin, K. H. (2003) · Archives of Pharmacal Research · doi:10.1007/bf02976680 · Cited by 168 · see citing works

Amyloidosis

Hazenberg, B. P. C. (2013) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2013.02.012 · Cited by 167 · see citing works

Antioxidant Effects of Phlorotannins Isolated from Ishige okamurae in Free Radical Mediated Oxidative Systems

Zou, Y., Qian, Z., Li, Y., Kim, M., Lee, S., & Kim, S. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf801133h · Cited by 162 · see citing works

Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model

Fang, F., Chen, X., Huang, T., Lue, L., Luddy, J. S., & Yan, S. S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.004 · Cited by 160 · see citing works

Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer’s disease

Lin, A., Jahrling, J. B., Zhang, W., DeRosa, N., Bakshi, V., Romero, P., Galván, V., & Richardson, A. G. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15621575 · Cited by 154 · see citing works

A double‐blind, placebo‐controlled, randomized trial ofGinkgo bilobaextract EGb 761® in a sample of cognitively intact older adults: neuropsychological findings

Mix, J. A., & Crews, W. D. (2002) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.412 · Cited by 153 · see citing works

Suppression of B cell activation by cyclosporin A, FK506 and rapamycin

Wicker, L. S., Boltz, R. C., Matt, V., Nichols, E. A., Peterson, L. B., & SIGAL, N. H. (1990) · European Journal of Immunology · doi:10.1002/eji.1830201017 · Cited by 150 · see citing works

36‐month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease

Soininen, H. S., Solomon, A., Visser, P. J., Hendrix, S. B., Blennow, K., Kivipelto, M., & Hartmann, T. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12172 · Cited by 149 · see citing works

Fucoxanthin Inhibits β-Amyloid Assembly and Attenuates β-Amyloid Oligomer-Induced Cognitive Impairments

Xiang, S., Liu, F., Lin, J., Chen, H., Huang, C., Chen, L., Zhou, Y., Ye, L., Zhang, K., Jin, J., et al. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b00805 · Cited by 145 · see citing works

Fucoxanthin, a Marine Carotenoid, Reverses Scopolamine-Induced Cognitive Impairments in Mice and Inhibits Acetylcholinesterase in Vitro

Lin, J., Huang, L., Yu, J., Xiang, S., Wang, J., Zhang, J., Yan, X., Cui, W., He, S., & Wang, Q. (2016) · Marine Drugs · doi:10.3390/md14040067 · Cited by 142 · see citing works

Neuroprotective Effects of Ginseng Phytochemicals: Recent Perspectives

Huang, X., Li, N., Pu, Y., Zhang, T., & Wang, B. (2019) · Molecules · doi:10.3390/molecules24162939 · Cited by 138 · see citing works

Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease.

Xu, S., Gao, Z., Weng, Z., Du, Z., Xu, W. A., Yang, J., Zhang, M. L., Tong, Z. H., Fang, Y., & Chai, X. S. (1995) · PubMed · Cited by 137 · see citing works

Inhibitory Effects and Molecular Mechanism of Dieckol Isolated from Marine Brown Alga on COX-2 and iNOS in Microglial Cells

Jung, W., Heo, S., Jeon, Y., Lee, C., Park, Y., Byun, H., Choi, Y. H., Park, S.-G., & Choi, I. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf9003913 · Cited by 137 · see citing works

Astaxanthin offers neuroprotection and reduces neuroinflammation in experimental subarachnoid hemorrhage

Zhang, X., Zhang, X., Wu, Q., Li, W., Wang, C.-X., Xie, G.-B., Zhou, X., Shi, J., & Zhou, M. (2014) · Journal of Surgical Research · doi:10.1016/j.jss.2014.05.029 · Cited by 134 · see citing works

Investigational BACE inhibitors for the treatment of Alzheimer’s disease

Imbimbo, B. P., & Watling, M. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1683160 · Cited by 132 · see citing works

Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer’s disease: results of a randomized, double-blind, placebo-controlled phase 2a study

Scheltens, P., Hallikainen, M., Grimmer, T., Duning, T., Gouw, A. A., Teunissen, C. E., Wink, A. M., Maruff, P., Harrison, J., van Baal, C. M., et al. (2018) · Alzheimer's Research &amp; Therapy · doi:10.1186/s13195-018-0431-6 · Cited by 129 · see citing works

Galantamine Enhances Dopaminergic Neurotransmission In Vivo Via Allosteric Potentiation of Nicotinic Acetylcholine Receptors

Schilström, B., Ivanov, V., Wiker, C., & Svensson, T. H. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301087 · Cited by 128 · see citing works

Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer’s Disease

Uddin, M. S., Kabir, M. T., Rahman, M. S., Behl, T., Jeandet, P., Ashraf, G. M., Najda, A., Bin-Jumah, M. N., El-Seedi, H. R., & Abdel‐Daim, M. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165858 · Cited by 127 · see citing works

Anti-ageing and antioxidant effects of sulfate oligosaccharides from green algae Ulva lactuca and Enteromorpha prolifera in SAMP8 mice

Liu, X., Liu, D., Lin, G., Wu, Y., Gao, L., Ai, C., Huang, Y., Wang, M.-F., El-Seedi, H. R., Chen, X., et al. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.07.195 · Cited by 125 · see citing works

Fucosterol isolated from Undaria pinnatifida inhibits lipopolysaccharide-induced production of nitric oxide and pro-inflammatory cytokines via the inactivation of nuclear factor-κB and p38 mitogen-activated protein kinase in RAW264.7 macrophages

Yoo, M., Shin, J., Choi, H., Cho, Y., Bang, M., Baek, N., & Lee, K. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2012.05.039 · Cited by 124 · see citing works

Pharmacological Profile of Huperzine A, a Novel Acetylcholinesterase Inhibitor from Chinese Herb

Tang, X. C., & Han, Y. (1999) · CNS Drug Reviews · doi:10.1111/j.1527-3458.1999.tb00105.x · Cited by 124 · see citing works

Anthocyanins protect against LPS-induced oxidative stress-mediated neuroinflammation and neurodegeneration in the adult mouse cortex

Khan, M. S., Ali, T., Kim, M. W., Jo, M. H., Jo, M. G., Badshah, H., & Kim, M. O. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.08.005 · Cited by 124 · see citing works

Anti-Neuroinflammatory Effects of Fucoxanthin via Inhibition of Akt/NF-κB and MAPKs/AP-1 Pathways and Activation of PKA/CREB Pathway in Lipopolysaccharide-Activated BV-2 Microglial Cells

Zhao, D. F., Kwon, S., Chun, Y. S., Gu, M., & Yang, H. O. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2123-6 · Cited by 124 · see citing works

Beijing urban particulate matter-induced injury and inflammation in human lung epithelial cells and the protective effects of fucosterol from Sargassum binderi (Sonder ex J. Agardh)

Fernando, I. P. S., Jayawardena, T. U., Kim, H.-S., Lee, W., Vaas, A. P. J. P., Silva, H. I. C. D., Abayaweera, G. S., Nanayakkara, C. M., Abeytunga, D. T. U., Lee, D.-S., et al. (2019) · Environmental Research · doi:10.1016/j.envres.2019.02.016 · Cited by 123 · see citing works

Amyloid-β Peptide: Dr. Jekyll or Mr. Hyde?

Puzzo, D., & Arancio, O. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129033 · Cited by 122 · see citing works

The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy

Siman, R., Cocca, R., & Dong, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142340 · Cited by 122 · see citing works

Ginkgo biloba Special Extract in Dementia with Neuropsychiatric Features

Napryeyenko, O., & Borzenko, I. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1296579 · Cited by 119 · see citing works

In vitro studies of the neuroprotective activities of astaxanthin and fucoxanthin against amyloid beta (Aβ1-42) toxicity and aggregation

Alghazwi, M., Smid, S. D., Musgrave, I., & Zhang, W. Y. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.01.010 · Cited by 116 · see citing works

Glutaminyl Cyclase in Human Cortex: Correlation with (pGlu)-Amyloid-β Load and Cognitive Decline in Alzheimer's Disease

Morawski, M., Schilling, S., Kreuzberger, M., Waniek, A., Jäger, C., Koch, B. M., Cynis, H., Kehlen, A., Arendt, T., Hartlage‐Rübsamen, M., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131535 · Cited by 114 · see citing works

Improvement of memory by dieckol and phlorofucofuroeckol in ethanol-treated mice: Possible involvement of the inhibition of acetylcholinesterase

Myung, C., Shin, H., Bao, H. Y., Yeo, S. J., Lee, B. H., & Kang, J. S. (2005) · Archives of Pharmacal Research · doi:10.1007/bf02969360 · Cited by 109 · see citing works

X-ray Structures of Torpedo californica Acetylcholinesterase Complexed with (+)-Huperzine A and (−)-Huperzine B: Structural Evidence for an Active Site Rearrangement,

Dvir, H., Jiang, H., Wong, D. M., Harel, M., Chetrit, M., He, X., Jin, G., Yu, G. L., Tang, X. C., Silman, I., et al. (2002) · Biochemistry · doi:10.1021/bi020151+ · Cited by 105 · see citing works

Neuroprotective effects of ginsenosides

Rausch, W., Liu, S., Gille, G., & Radad, A. (2006) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2006-1625 · Cited by 104 · see citing works

Rapamycin protects the mitochondria against oxidative stress and apoptosis in a rat model of Parkinson’s disease

JIANG, J., Jiang, J., Zuo, Y., & Gu, Z. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1280 · Cited by 101 · see citing works

Fucoxanthin Ameliorates Inflammation and Oxidative Reponses in Microglia

Pangestuti, R., Vo, T., Ngo, D., & Kim, S. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf400015k · Cited by 99 · see citing works

Kinetics and molecular docking studies of fucosterol and fucoxanthin, BACE1 inhibitors from brown algae Undaria pinnatifida and Ecklonia stolonifera

Jung, H. A., Ali, M. Y., Choi, R. J., Jeong, H. O., Chung, H. Y., & Choi, J. S. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.01.014 · Cited by 99 · see citing works

Pyroglutamate Aβ cascade as drug target in Alzheimer’s disease

Bayer, T. A. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01409-2 · Cited by 98 · see citing works

Acetylcholinesterase inhibitory activity of phlorotannins isolated from the brown alga, Ecklonia maxima (Osbeck) Papenfuss

Rengasamy, K. R. R., Aderogba, M. A., Ndhlala, A. R., Stirk, W. A., & Staden, J. V. (2012) · Food Research International · doi:10.1016/j.foodres.2012.11.017 · Cited by 97 · see citing works

Ginsenosides and Their CNS Targets

Radad, K., Moldzio, R., & Rausch, W. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00208.x · Cited by 96 · see citing works

The Allosteric Potentiation of Nicotinic Acetylcholine Receptors by Galantamine Is Transduced into Cellular Responses in Neurons: Ca2+ Signals and Neurotransmitter Release.

Dajas‐Bailador, F., Heimala, K., & Wonnacott, S. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.5.1217 · Cited by 96 · see citing works

Genetic Heterogeneity in Alzheimer Disease and Implications for Treatment Strategies

Dominantly Inherited Alzheimer Network, Ringman, J. M., Goate, A., Masters, C. L., Cairns, N. J., Danek, A., Graff-Radford, N., Ghetti, B., & Morris, J. C. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0499-8 · Cited by 96 · see citing works

Alginate-Derived Oligosaccharide Inhibits Neuroinflammation and Promotes Microglial Phagocytosis of β-Amyloid

Zhou, R., Shi, X., Bi, D., Fang, W., Wei, G., & Xu, X. (2015) · Marine Drugs · doi:10.3390/md13095828 · Cited by 95 · see citing works

Anticholinesterase activity of plastoquinones from Sargassum sagamianum: lead compounds for alzheimer's disease therapy

Choi, B. W., Ryu, G., Park, S. H., Kim, E. S., Shin, J., Roh, S. S., Shin, H., & Lee, B. H. (2007) · Phytotherapy Research · doi:10.1002/ptr.2090 · Cited by 94 · see citing works

Fucoidan Protects against Lipopolysaccharide‐Induced Rat Neuronal Damage and Inhibits the Production of Proinflammatory Mediators in Primary Microglia

Cui, Y., Jia, Y., Zhang, T., Zhang, Q., & Wang, X. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2012.00372.x · Cited by 91 · see citing works

Contemporary Anticholinesterase Pharmaceuticals of Natural Origin and Their Synthetic Analogues for the Treatment of Alzheimers Disease

Orhan, G., Orhan, I., Subutay-Oztekin, N., Ak, F., & Sener, B. (2009) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488909787002582 · Cited by 90 · see citing works

Anti-Neuroinflammatory Property of Phlorotannins from Ecklonia cava on Aβ25-35-Induced Damage in PC12 Cells

Lee, S., Youn, K., Kim, D. H., Ahn, M., Yoon, E., Kim, O. Y., & Jun, M. (2018) · Marine Drugs · doi:10.3390/md17010007 · Cited by 89 · see citing works

The dynamics of biomarkers across the clinical spectrum of Alzheimer's disease

Hadjichrysanthou, C., Evans, S., Bajaj, S., Siakallis, L. C., McRae-McKee, K., de Wolf, F., Anderson, R. M., & Initiative, T. A. D. N. (2020) · Alzheimer's Research &amp; Therapy · doi:10.1186/s13195-020-00636-z · Cited by 86 · cited 2× · see citing works

Identification of chemical structure and free radical scavenging activity of diphlorethohydroxycarmalol isolated from a brown alga, Ishige okamurae.

Heo, S.-J., Kim, J.-P., Jung, W., Lee, N.-H., Kang, H., Jun, E., Park, S.-H., Kang, S., Lee, Y.-J., Park, P.-J., et al. (2008) · PubMed · Cited by 85 · see citing works

Open questions for Alzheimer’s disease immunotherapy

Golde, T. E. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt233 · Cited by 85 · see citing works

Compound K derived from ginseng: neuroprotection and cognitive improvement

Oh, J., & Kim, J. (2016) · Food & Function · doi:10.1039/c6fo01077f · Cited by 84 · see citing works

Huperzine-A in capsules and tablets for treating patients with Alzheimer disease.

Xu, S.-S., Cai, Z., Qu, Z., Yang, R., Cai, Y.-L., Wang, G.-Q., Xue-qian, S., Zhong, X.-S., Cheng, R.-Y., Xu, W.-A., et al. (1999) · PubMed · Cited by 81 · see citing works

Ginkgo biloba for mild to moderate dementia in a community setting: a pragmatic, randomised, parallel‐group, double‐blind, placebo‐controlled trial

McCarney, R., Fisher, P., Iliffe, S., van Haselen, R. A., Griffin, M., van der Meulen, J., & Warner, J. P. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2055 · Cited by 79 · see citing works

Cholinesterase inhibition by galanthamine and lycoramine

Irwin, R. L., & Smith, H. J. (1960) · Biochemical Pharmacology · doi:10.1016/0006-2952(60)90030-7 · Cited by 78 · see citing works

Protective effect of cyanidin 3-O-glucoside on beta-amyloid peptide-induced cognitive impairment in rats

Qin, L., Zhang, J., & Qin, M. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.12.023 · Cited by 77 · see citing works

[Anti-cholinesterase activity of huperzine A].

Wang, Y. E., Yue, D.-X., & Tang, X.-L. (1986) · PubMed · Cited by 77 · see citing works

Physostigmine for dementia due to Alzheimer's disease

Filho, J. M. J. C., & Birks, J. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001499 · Cited by 76 · see citing works

Cerebral amyloidosis: amyloid subunits, mutants and phenotypes

Rostagno, A. A., Holton, J. L., Lashley, T., Révész, T., & Ghiso, J. A. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0182-4 · Cited by 76 · see citing works

Floridoside suppresses pro-inflammatory responses by blocking MAPK signaling in activated microglia

Kim, M., Li, Y.-X., Dewapriya, P., Ryu, B., & Kim, S. (2013) · BMB Reports · doi:10.5483/bmbrep.2013.46.8.237 · Cited by 75 · see citing works

Modulation of Nicotinic Receptor Activity in the Central Nervous System

Albuquerque, E. X., Santos, M. D., Alkondon, M., Pereira, E. F. R., & Maelicke, A. (2001) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200108001-00004 · Cited by 72 · see citing works

MECHANISM OF THE COMBINATION IMMUNOSUPPRESSIVE EFFECTS OF RAPAMYCIN WITH EITHER CYCLOSPORINE OR TACROLIMUS

Khanna, A. K. (2000) · Transplantation · doi:10.1097/00007890-200008270-00027 · Cited by 72 · see citing works

The Use of Physostigmine by Toxicologists in Anticholinergic Toxicity

Watkins, J. W., Schwarz, E. S., Arroyo-Plasencia, A. M., & Mullins, M. E. (2014) · Journal of Medical Toxicology · doi:10.1007/s13181-014-0452-x · Cited by 70 · see citing works

New kilogram-synthesis of the anti-alzheimer drug (−)-galanthamine

Czollner, L., Frantsits, W., Küenburg, B., Hedenig, U., Fröhlich, J., & Jordis, U. (1998) · Tetrahedron Letters · doi:10.1016/s0040-4039(98)00294-9 · Cited by 70 · see citing works

[Drug evaluation of huperzine A in the treatment of senile memory disorders].

ZHANG, R.-Q., Tang, X. C., Han, Y. Y., Sang, G.-W., Zhang, Y. D., X, Y., ZHANG, C.-W., & Yang, R. M. (1991) · PubMed · Cited by 69 · see citing works

Effect of a short- and long-term treatment with Ginkgo biloba extract on Amyloid Precursor Protein Levels in a transgenic mouse model relevant to Alzheimer’s disease

Augustin, S., Rimbach, G. H., Augustin, K., Schliebs, R., Wolffram, S., & Cermak, R. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.10.032 · Cited by 69 · see citing works

Anticholinesterase and Antioxidant Activities of Fucoxanthin Purified from the Microalga Phaeodactylum Tricornutum

Kawee‐ai, A., Kuntiya, A., & Kim, S. M. (2013) · Natural Product Communications · doi:10.1177/1934578x1300801010 · Cited by 68 · see citing works

Involvement of GSK3 and PP2A in ginsenoside Rb1's attenuation of aluminum-induced tau hyperphosphorylation

Zhao, H., Di, J., Liu, W.-S., Liu, H., Lai, H., & Lu, Y. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.11.037 · Cited by 68 · see citing works

The Case of Galantamine: Repurposing and Late Blooming of a Cholinergic Drug

Mucke, H. A. (2015) · Future Science OA · doi:10.4155/fso.15.73 · Cited by 68 · see citing works

Adverse Effects of Physostigmine

Arens, A. M., & Kearney, T. (2019) · Journal of Medical Toxicology · doi:10.1007/s13181-019-00697-z · Cited by 68 · see citing works

Iron elevations in the aging Parkinsonian brain: a consequence of impaired iron homeostasis?

Lee, D. W., & Andersen, J. K. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06470.x · Cited by 62 · see citing works

Potencies and stereoselectivities of enantiomers of huperzine A for inhibition of rat cortical acetylcholinesterase

McKinney, M., Miller, J. H., Yamada, F., Tückmantel, W., & Kozikowski, A. P. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90730-e · Cited by 62 · see citing works

BACE1 inhibitory activity and molecular docking analysis of meroterpenoids from Sargassum serratifolium

Seong, S. H., Ali, M. Y., Kim, H., Jung, H. A., & Choi, J. S. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.05.033 · Cited by 61 · see citing works

Secretases in Alzheimer's disease: Novel insights into proteolysis of APP and TREM2

Lichtenthaler, S. F., Tschirner, S. K., & Steiner, H. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.09.003 · Cited by 60 · see citing works

Anticholinesterase effects of huperzine A, E2020, and tacrine in rats.

Wang, H., & Tang, X. C. (1998) · PubMed · Cited by 59 · see citing works

8,8′-Bieckol, isolated from edible brown algae, exerts its anti-inflammatory effects through inhibition of NF-κB signaling and ROS production in LPS-stimulated macrophages

Yang, Y., Jung, S., Lee, K., & Choi, J. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.09.019 · Cited by 59 · see citing works

Anti-Alzheimers and anti-inflammatory activities of a glycoprotein purified from the edible brown alga Undaria pinnatifida

Rafiquzzaman, S. M., Kim, E. Y., Lee, J. M., Mohibbullah, M., Alam, M. B., Moon, I. S., Kim, J., & Kong, I. (2015) · Food Research International · doi:10.1016/j.foodres.2015.08.021 · Cited by 59 · see citing works

Turning the tide on Alzheimer’s disease: modulation of γ-secretase

Luo, J. E., & Li, Y.-M. (2022) · Cell &amp; Bioscience · doi:10.1186/s13578-021-00738-7 · Cited by 59 · see citing works

Possible mechanisms of the protection of ginsenoside Re against MPTP-induced apoptosis in substantia nigra neurons of Parkinson's disease mouse model

Xu, B., Liu, C., Gao, X., Zhang, W., Wang, S., & Cao, Y.-L. (2004) · Journal of Asian Natural Products Research · doi:10.1080/10286020410001690172 · Cited by 58 · see citing works

Trans-astaxanthin attenuates lipopolysaccharide-induced neuroinflammation and depressive-like behavior in mice

Jiang, X., Chen, L., Shen, L., Chen, Z., Xu, L., Zhang, J., & Yu, X. (2016) · Brain Research · doi:10.1016/j.brainres.2016.08.029 · Cited by 58 · see citing works

Natural Products from Microalgae with Potential against Alzheimer’s Disease: Sulfolipids Are Potent Glutaminyl Cyclase Inhibitors

Hielscher-Michael, S., Griehl, C., Buchholz, M., Demuth, H., Arnold, N., & Wessjohann, L. A. (2016) · Marine Drugs · doi:10.3390/md14110203 · Cited by 57 · see citing works

Stereoselectivities of enantiomers of huperzine A in protection against β-amyloid25–35-induced injury in PC12 and NG108-15 cells and cholinesterase inhibition in mice

Zhang, H., Liang, Y. Q., Tang, X. C., He, X., & Bai, D. L. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02437-5 · Cited by 56 · see citing works

Eckmaxol, a Phlorotannin Extracted from Ecklonia maxima , Produces Anti-β-amyloid Oligomer Neuroprotective Effects Possibly via Directly Acting on Glycogen Synthase Kinase 3β

Wang, J., Zheng, J., Huang, C., Zhao, J., Lin, J., Zhou, X., Naman, C. B., Wang, N., Gerwick, W. H., Wang, Q., et al. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00527 · Cited by 54 · see citing works

The Applications of Focused Ultrasound (FUS) in Alzheimer’s Disease Treatment: A Systematic Review on Both Animal and Human Studies

Liu, X., Naomi, S. S. M., Sharon, W. L., & Russell, E. J. (2021) · Aging and Disease · doi:10.14336/ad.2021.0510 · Cited by 53 · see citing works

Phlorofucofuroeckol B suppresses inflammatory responses by down-regulating nuclear factor κB activation via Akt, ERK, and JNK in LPS-stimulated microglial cells

Yu, D.-K., Lee, B., Kwon, M., Yoon, N., Shin, T., Kim, N.-G., Choi, J., & Kim, H. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.08.028 · Cited by 50 · see citing works

Antiaggregation Potential of Padina gymnospora against the Toxic Alzheimer’s Beta-Amyloid Peptide 25–35 and Cholinesterase Inhibitory Property of Its Bioactive Compounds

Shanmuganathan, B., Malar, D. S., Sathya, S., & Devi, K. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141708 · Cited by 50 · see citing works

Reversal of Central Anticholinergic Syndrome by Galanthamine

Baraka, A. (1977) · JAMA · doi:10.1001/jama.1977.03280220061024 · Cited by 49 · see citing works

Cyanobacterial peptides as a prototype for the design of potent β-secretase inhibitors and the development of selective chemical probes for other aspartic proteases.

Liu, Y., Zhang, W., Li, L., Salvador, L. A., Chen, T., Chen, W.-Y., Felsenstein, K., Ladd, T., Price, A. R., Golde, T., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301630s · Cited by 49 · see citing works

Anti-amyloidogenic and anti-apoptotic effect of α-bisabolol against Aβ induced neurotoxicity in PC12 cells

Shanmuganathan, B., Suryanarayanan, V., Sathya, S., Narenkumar, M., Singh, S. K., Kandasamy, R., & Devi, K. P. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.10.017 · Cited by 49 · see citing works

SODIUM EXCLUSION AND POTASSIUM RETENTION BY THE RED MARINE ALGA, PORPHYRA PERFORATA

Eppley, R. W. (1958) · The Journal of General Physiology · doi:10.1085/jgp.41.5.901 · Cited by 48 · see citing works

Physostigmine: A Plant Alkaloid Isolated from Physostigma venenosum: A Review on Pharmacokinetics, Pharmacological and Toxicological Activities

Batiha, G. E., Alkazmi, L. M., Nadwa, E. H., Rashwan, E. K., Beshbishy, A. M., Shaheen, H. M., & Wasef, L. (2020) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v10i1-s.3866 · Cited by 47 · see citing works

Immunomodulatory Function of κ-Carrageenan Oligosaccharides Acting on LPS-Activated Microglial Cells

Yao, Z., Xu, L., & Wu, H. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1228-4 · Cited by 46 · see citing works

Fucosterol protects cobalt chloride induced inflammation by the inhibition of hypoxia-inducible factor through PI3K/Akt pathway

Sun, Z., Mohamed, M. A. A., Park, S. Y., & Yi, T. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.09.016 · Cited by 45 · see citing works

Protective effect of fucosterol isolated from the edible brown algae,Ecklonia stoloniferaandEisenia bicyclis, ontert-butyl hydroperoxide- and tacrine-induced HepG2 cell injury

Choi, J. S., Han, Y. R., Byeon, J. S., Choung, S., Sohn, H. S., & Jung, H. A. (2015) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12404 · Cited by 44 · see citing works

Tasiamide F, a potent inhibitor of cathepsins D and E from a marine cyanobacterium

Al‐Awadhi, F. H., Ratnayake, R., Paul, V. J., & Luesch, H. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.04.062 · Cited by 43 · see citing works

6,6′-Bieckol suppresses inflammatory responses by down-regulating nuclear factor-κB activation via Akt, JNK, and p38 MAPK in LPS-stimulated microglial cells

Kim, A.-R., Lee, B., Joung, E., Gwon, W., Utsuki, T., Kim, N.-G., & Kim, H. (2016) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2016.1173060 · Cited by 43 · see citing works

Fucosterol inhibits the cholinesterase activities and reduces the release of pro-inflammatory mediators in lipopolysaccharide and amyloid-induced microglial cells

Wong, C. H., Gan, S. Y., Tan, S. C., Gany, S. A., Ying, T., Gray, A. I., Igoli, J. O., Chan, E. W. L., & Phang, S. M. (2018) · Journal of Applied Phycology · doi:10.1007/s10811-018-1495-1 · Cited by 42 · see citing works

Phlorofucofuroeckol A Suppresses Expression of Inducible Nitric Oxide Synthase, Cyclooxygenase-2, and Pro-inflammatory Cytokines via Inhibition of Nuclear Factor-κB, c-Jun NH2-Terminal Kinases, and Akt in Microglial Cells

Kim, A.-R., Lee, M., Choi, J.-W., Utsuki, T., Kim, J., Jang, B., & Kim, H. (2012) · Inflammation · doi:10.1007/s10753-012-9542-6 · Cited by 40 · see citing works

Anti-Alzheimer’s Disease Activity of Bromophenols from a Red Alga, Symphyocladia latiuscula (Harvey) Yamada

Paudel, P., Seong, S. H., Zhou, Y., Park, H. J., Jung, H. A., & Choi, J. S. (2019) · ACS Omega · doi:10.1021/acsomega.9b01557 · Cited by 40 · see citing works

Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities

Zhan, Z., Bian, H.-L., Wang, J., & Shan, W. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.01.097 · Cited by 38 · see citing works

Identifying Phlorofucofuroeckol-A as a Dual Inhibitor of Amyloid-β25-35 Self-Aggregation and Insulin Glycation: Elucidation of the Molecular Mechanism of Action

Seong, S. H., Paudel, P., Jung, H. A., & Choi, J. S. (2019) · Marine Drugs · doi:10.3390/md17110600 · Cited by 35 · see citing works

The latest suspect

Tanzi, R. E., & Bertram, L. (2008) · Nature · doi:10.1038/454706a · Cited by 34 · see citing works

Structure-based drug discovery and protein targets in the CNS

Hubbard, R. E. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.07.016 · Cited by 33 · see citing works

Pharmacokinetics of physostigmine in man following a single application of a transdermal system.

Walter, K., Müller, M., Barkworth, M. F., von Nieciecki, A., & Stanislaus, F. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb04410.x · Cited by 32 · see citing works

Extended-release physostigmine in Alzheimer disease: a multicenter, double-blind, 12-week study with dose enrichment. Physostigmine Study Group.

van Dyck, C. H., Newhouse, P., Falk, W. E., & Mattes, J. A. (2000) · PubMed · doi:10.1001/archpsyc.57.2.157 · Cited by 30 · see citing works

Effects of ginseol k-g3, an Rg3-enriched fraction, on scopolamine-induced memory impairment and learning deficit in mice

Peña, I. D., Yoon, S. Y., Kim, H. J., Park, S., Hong, E. Y., Ryu, J. H., Park, I. H., & Cheong, J. H. (2014) · Journal of Ginseng Research · doi:10.1016/j.jgr.2013.11.003 · Cited by 30 · see citing works

Lycoris Alkaloids. XXIV. : Isolation and Characterization of Lycoremine.

Uyeo, S., & Kobayashi, S. (1953) · Pharmaceutical Bulletin · doi:10.1248/cpb1953.1.139 · Cited by 28 · see citing works

Sargaquinoic acid isolated from Sargassum siliquastrum inhibits lipopolysaccharide-induced nitric oxide production in macrophages via modulation of nuclear factor-κB and c-Jun N -terminal kinase pathways

Kang, G.-J., Han, S.-C., Yoon, W., Koh, Y. S., Hyun, J., Kang, H.-K., Cho, J. Y., & Yoo, E.-S. (2012) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2012.698622 · Cited by 28 · see citing works

[Effects of huperzine A and B on skeletal muscle and the electroencephalogram].

Yan, X., Lu, W.-H., Lou, W.-J., & Tang, X. C. (1987) · PubMed · Cited by 28 · see citing works

In vitro and in silico evaluation of fucosterol from Sargassum horridum as potential human acetylcholinesterase inhibitor

Castro-Silva, E. S., Bello, M., Rodríguez, M. H., Correa‐Basurto, J., Murillo-Álvarez, J. I., Rosales‐Hernández, M. C., & Muñoz‐Ochoa, M. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1505551 · Cited by 28 · see citing works

Effect of Ginkgo biloba extract (EGb761) on glucose metabolism-related markers in streptozotocin-damaged rat brain

Löffler, T., Lee, S. K., Nöldner, M., Chatterjee, S. S., Hoyer, S., & Schliebs, R. (2001) · Journal of Neural Transmission · doi:10.1007/s007020100020 · Cited by 27 · see citing works

YXQN Reduces Alzheimer’s Disease-Like Pathology and Cognitive Decline in APPswePS1dE9 Transgenic Mice

Wang, X., Song, R., Lu, W., Liu, Z., Wang, L., Zhu, X., Liu, Y., Sun, Z., Li, J., & Li, X. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00157 · Cited by 27 · see citing works

Randomized Trial of Marine n-3 Polyunsaturated Fatty Acids for the Prevention of Cerebral Small Vessel Disease and Inflammation in Aging (PUFA Trial): Rationale, Design and Baseline Results

Bowman, G. L., Silbert, L. C., Dodge, H. H., Lahna, D. L., Hagen, K., Murchison, C., Howieson, D. B., Kaye, J. A., Quinn, J. F., & Shinto, L. H. (2019) · Nutrients · doi:10.3390/nu11040735 · Cited by 26 · see citing works

Sargachromenol from Sargassum micracanthum Inhibits the Lipopolysaccharide‐Induced Production of Inflammatory Mediators in RAW 264.7 Macrophages

Yang, E. J., Ham, Y., Yang, K.-W., Lee, N. H., & Hyun, C. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/712303 · Cited by 25 · see citing works

Seleno-polymannuronate attenuates neuroinflammation by suppressing microglial and astrocytic activation

Bi, D., Lai, Q., Han, Q., Cai, N., He, H., Fang, W., Yi, J., Li, X., Xu, H. Y., Li, X., et al. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.10.010 · Cited by 25 · see citing works

The treatment of Alzheimer's disease

Allen, N. H. P., & Burns, A. S. (1995) · Journal of Psychopharmacology · doi:10.1177/026988119500900108 · Cited by 23 · see citing works

Marine glycan-derived therapeutics in China

Gao, Y., Zhang, L., & Jiao, W. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.02.006 · Cited by 23 · see citing works

Glutaminyl Cyclases as Novel Targets for the Treatment of Septic Arthritis

Hellvard, A., Maresz, K., Schilling, S., Graubner, S., Heiser, U. F., Jonsson, R., Cynis, H., Demuth, H., Potempa, J., & Mydel, P. M. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis729 · Cited by 21 · see citing works

A novel BACE inhibitor isolated from Eisenia bicyclis exhibits neuroprotective activity against β-amyloid toxicity

Lee, J. K., & Byun, H. (2018) · Fisheries and aquatic sciences · doi:10.1186/s41240-018-0114-z · Cited by 19 · see citing works

Apoptosis induced by beta-amyloid25-35 in acetylcholinesterase-overexpressing neuroblastoma cells.

Zhang, H. Y., Brimijoin, S., & Tang, X. (2003) · PubMed · Cited by 14 · see citing works

Acetylcholinesterase as a target of halogenated marine natural products from Laurencia dendroidea

Gonçalves, K. G., da Silva, L. L., Soares, A. R., & Romeiro, N. C. (2020) · Algal Research · doi:10.1016/j.algal.2020.102130 · Cited by 13 · see citing works

Brief treatment with rapamycin in vivo increases responsiveness to alloantigens measured by the mixed lymphocyte response

Mohaçsi, P., & Morris, R. E. (1992) · Immunology Letters · doi:10.1016/0165-2478(92)90224-c · Cited by 7 · see citing works

Lipid content determines aggregation of neuromelanin granules in vitro

Dedov, V. N., Griffiths, F. M., Garner, B., Halliday, G. M., & Double, K. L. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_5 · Cited by 6 · see citing works

Isolation of 6,6'-Bieckol from Grateloupia elliptica and its Antioxidative and Anti-Cholinesterase Activity

Lee, B. H., Choi, B. W., & Lee, S. (2017) · Ocean and Polar Research · doi:10.4217/opr.2017.39.1.045 · Cited by 6 · see citing works

[The use of galantamine bromhydrate (nivaline) in the paralytic sequelae of poliomyelitis, neuraxitis and in muscular dystrophy].

LOMBARDO, G., & ARENA, G. (1962) · PubMed · Cited by 3 · see citing works

THE CLINICAL APPLICATION OF NIVALIN AS AN ANTIDOTE OF CURARE.

Stoyanov, E., & Vulchanova, S. (1963) · PubMed · Cited by 2 · see citing works

Unlocking the Therapeutic Potential of Medicinal Plants for Alzheimer’s Disease: Preclinical to Clinical Trial Insights

Nagori, K., Nakhate, K. T., Yadav, K., Ajazuddin, & Pradhan, M. (2023) · Future Pharmacology · doi:10.3390/futurepharmacol3040053 · Cited by 61 · see citing works

Anti-Neuroinflammatory Potential of Natural Products in the Treatment of Alzheimer’s Disease

Deng, M., Yan, W., Gu, Z., Li, Y., Chen, L., & He, B. (2023) · Molecules · doi:10.3390/molecules28031486 · Cited by 34 · see citing works

Recent Progress in Research on Mechanisms of Action of Natural Products against Alzheimer’s Disease: Dietary Plant Polyphenols

Wang, Y., Wang, K., Yan, J., Zhou, Q., & Wang, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213886 · Cited by 29 · see citing works

Study on the mechanism of Coptis chinensis Franch. And its main active components in treating Alzheimer's disease based on SCFAs using Orbitrap Fusion Lumos Tribrid MS

Xie, M., Gu, S., Hong, Y., Liu, Y., Rong, X., Lu, W., Liu, H., Algradi, A. M., Naseem, A., Shu, Z., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116392 · Cited by 22 · see citing works

Abelmoschus eculentus Seed Extract Exhibits In Vitro and In Vivo Anti-Alzheimer’s Potential Supported by Metabolomic and Computational Investigation

Bakhsh, H. T., Mokhtar, F. A., Elmaidomy, A. H., Aly, H. F., Younis, E. A., Alzubaidi, M. A., Altemani, F. H., Algehainy, N. A., Majrashi, M., Alsenani, F., et al. (2023) · Plants · doi:10.3390/plants12122382 · Cited by 22 · see citing works

A Review of African Medicinal Plants and Functional Foods for the Management of Alzheimer's Disease-related Phenotypes, Treatment of HSV-1 Infection and/or Improvement of Gut Microbiota

Tettevi, E. J., Maina, M. B., Simpong, D. L., Osei-Atweneboana, M. Y., & Ocloo, A. (2022) · Journal of Evidence-Based Integrative Medicine · doi:10.1177/2515690x221114657 · Cited by 17 · see citing works

The Potential of Edible and Medicinal Resource Polysaccharides for Prevention and Treatment of Neurodegenerative Diseases

Gan, Q., Ding, Y., Peng, M., Chen, L., Dong, J., Hu, J., & Ma, Y. (2023) · Biomolecules · doi:10.3390/biom13050873 · Cited by 16 · see citing works

Review on dietary supplements as an effective improvement of Alzheimer’s disease: focus on structures and mechanisms

Li, S., Wei, Y., Liang, Z., Guo, L., Hao, X., & Zhang, Y. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250150 · Cited by 16 · see citing works

Comparison of the efficacy of updated drugs for the treatment on the improvement of cognitive function in patients with Alzheimer ’s disease: A systematic review and network meta- analysis

Cao, W., Zhu, B., Liu, Z., Jia, X.-T., Zhao, H., Gu, N., Chang, H., Xi, J., Li, R., Guo, K., et al. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.11.029 · Cited by 10 · see citing works

Neurobiotech innovative strategies targeting Alzheimer's disease through therapeutic micro and macroalgae potentials

Wagdy, M., Ibrahim, A. A., Yahia, A. M., Maher, R. M., Abo-Elwafa, A. H., Salah, A., & Heikal, Y. M. (2025) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2025.578821 · Cited by 2 · see citing works

Pathophysiological Linkage between Aging and Cognitive Decline: Implications for Dementia Treatment

D'Arrigo, J. S. (2022) · OBM Integrative and Complementary Medicine · doi:10.21926/obm.icm.2204054 · Cited by 2 · see citing works

An AS‐qPCR‐based method for the detection of Alzheimer's disease‐related SNPs

Chen, J., Shi, B., Li, Y., Feng, Y., Ni, J., Shi, J., Luo, C., Wang, J., & Tian, J. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30350 · Cited by 2 · see citing works

Vascular Risks, Aging, and Late-Onset Dementia: Overlapping Etiologies Point to 'Scavenger Receptor'-Mediated Therapeutics

D'Arrigo, J. S. (2023) · OBM Geriatrics · doi:10.21926/obm.geriatr.2303244 · Cited by 2 · see citing works

Development and Validation of LC–MS/MS Method for Quantitation of Sodium Oligomannate in Human Plasma, Urine and Feces

Zhang, Z., Yang, X. H., Zhang, L., Zhu, H., Huang, B., Chen, Q., Wang, Y., Chen, Y., Bi, L., Geng, M., et al. (2023) · Bioanalysis · doi:10.4155/bio-2023-0026 · Cited by 1 · see citing works

In vitro and in silico assessment of anti-cholinesterase potential of Ricinus communis L. (Euphorbiaceae): furnished with network pharmacology

Karimi, I., Mohammed, L. J., Yousofvand, N., Abdulhussein, J. M., & Hussein, B. A. (2024) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-024-00749-y · Cited by 1 · see citing works

Alzheimer's disease: A role of biomarkers in early diagnosis and evidences from African ethnomedicinal knowledge

Balkrishna, A., Verma, S., Singh, S. K., & Arya, V. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.16050

Microalgae as Multiproduct Cell Factories

Makay, K., & Grewe, C. B. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1002273

Potential Medicinal Plants Used in the Treatment of Alzheimer’s Disease

Karageçili, H. (2024) · doi:10.69860/nobel.9786053359357.5

HPTLC-based Bioassay Screening of Selected Indigenous Plants for Acetylcholinesterase Inhibitory Activity

Kumari, P., Sarwa, N., & Chaudhary, N. S. (2025) · Current Enzyme Inhibition · doi:10.2174/0115734080356410250407092844

Masupirdine, a Selective Serotonin 5-HT 6 Receptor Antagonist for Alzheimer’s Disease

Toledano‐Pinedo, M., Iriepa, I., Rodríguez-Fernández, M. M., & Marco‐Contelles, J. (2026) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00818

Chemical composition and molecular docking analysis of essential oils from the endemic Sideritis argyrea P.H.Davis in Türkiye

Özer, E., GÜNEŞ, F., Yuca, H., Çeçen, Ö., Aydın, B., Demırcı, B., & Karakaya, S. (2026) · Journal of Essential Oil Research · doi:10.1080/10412905.2026.2629808

Natural Products as Effective Treatment Approach for Alzheimer's Disease: In silico Justification

Khamkat, P., Chatterjee, B. K., Barık, V., Sahu, S., & Mukherjee, S. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898815646126010015

Phenolic Compounds from Seaweeds and Human Health

Suryaningtyas, I. T., Je, J., Kim, S., & Pangestuti, R. (2026) · Springer eBooks · doi:10.1007/978-3-642-36202-6_275-1

Selected Natural Products in Neuroprotective Strategies for Alzheimer’s Disease—A Non-Systematic Review

Wojtunik‐Kulesza, K. A., Oniszczuk, T., Mołdoch, J., Kowalska, I., Szponar, J., & Oniszczuk, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031212 · Cited by 15 · see citing works

Therapeutic Potential of Natural Products in Treating Neurodegenerative Disorders and Their Future Prospects and Challenges

Rahman, M. H., Bajgai, J., Fadriquela, A., Sharma, S., Trinh, T. T., Akter, R., Jeong, Y. J., Goh, S. H., Kim, C.-S., & Lee, K.-J. (2021) · Molecules · doi:10.3390/molecules26175327 · Cited by 182 · see citing works

Role of natural products for the treatment of Alzheimer’s disease

Noori, T., Dehpour, A. R., Sureda, A., Sobarzo-Sanchez, E., & Shirooie, S. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173974 · Cited by 141 · see citing works

Neuroprotective Natural Products for Alzheimer’s Disease

Chen, X., Drew, J., Berney, W., & Lei, W. (2021) · Cells · doi:10.3390/cells10061309 · Cited by 236 · see citing works

Natural Products as Supporting Alternative in Alzheimer's Treatment

López-Romero, J. C., Moreno, H. T., Tapia-Rodríguez, M. R., Vidal-Gutiérrez, M., & Reyna-Urrutia, V. A. (2025) · CRC Press eBooks · doi:10.1201/9781003467304-10